Skip to content

Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome

Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome-A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05082597
Enrollment
20
Registered
2021-10-19
Start date
2021-10-13
Completion date
2025-03-31
Last updated
2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axillary Web Syndrome, Breast Cancer, Lymphedema, Extracorporeal Shock Wave Therapy

Brief summary

Axillary web syndrome(AWS) is common complication of breast cancer surgery. Overall, AWS affects more than a half of the patient receiving axillary lymph node dissection. The symptoms of AWS include pain, limited function and range of motion. Geater risk of secondary lymphedema was found if the patient developed AWS during the first postoperative year. ESWT was used for treating myofascial pain for decades. Low energy ESWT combined with complex decongestive therapy had a benefit on shoulder joint ROM and skin thickness improvement in patients with BCRL in recently studies. Investigators wonder if ESWT can also be applied to patients with axillary web syndrome for increasing ROM and relieving pain. The aim of this study was to evaluate the therapeutic effects of low energy ESWT in patients with axillary web syndrome.

Detailed description

Although the anticipated enrollment was 30 participants, the study was completed with 20 participants due to early attainment of statistical significance and recruitment feasibility.

Interventions

Therapeutic sessions: 4(once a week, for 4 weeks) Total dosage: 2500 shoots over axillary cord lesion (1000 over most fibrotic area, 500 over upper arm, 500 over forearm, 500 over other area) Energy: 0.056-0.065mJ/mm2

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Axillary web syndrome patient 2. Unilateral breast cancer and received related operation(mastectomy/ALND/SLND) 3. Completion of beast related chemotherapy or radiotherapy 4. Age with 20-65 years old

Exclusion criteria

1. Ongoing metastasis or recurrence of the breast cancer 2. Other cancer history 3. Lymphatic transplantation or reconstruction 4. Wound, infection or trauma over affected arm 5. Coagulopathy or poor circulation 6. Pregnancy 7. Oral anticoagulant using

Design outcomes

Primary

MeasureTime frameDescription
Shoulder range of motion2 monthsFlexion, extension, external rotation, internal rotation, abduction over upper limbs
Pain score2 monthsVisual Analogue Scale (0-10 points, higher score represented higher degree of pain)

Secondary

MeasureTime frameDescription
Muscle strength2 monthsMuscle strength of upper limb measured by ergometer
Upper limb functional score2 monthsquick Disabilities of the Arm, Shoulder and Hand Score(qDASH) (0-100 points, higher score indicated higher level of upper limb impairment)

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026